186 related articles for article (PubMed ID: 37958700)
1. Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer.
Scebba F; Salvadori S; Cateni S; Mantellini P; Carozzi F; Bisanzi S; Sani C; Robotti M; Barravecchia I; Martella F; Colla V; Angeloni D
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958700
[TBL] [Abstract][Full Text] [Related]
2. Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.
Ishikawa S; Ishizawa K; Tanaka A; Kimura H; Kitabatake K; Sugano A; Edamatsu K; Ueda S; Iino M
In Vivo; 2021; 35(1):541-547. PubMed ID: 33402507
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.
Tajmul M; Parween F; Singh L; Mathur SR; Sharma JB; Kumar S; Sharma DN; Yadav S
Int J Biol Macromol; 2018 Mar; 108():503-514. PubMed ID: 29222021
[TBL] [Abstract][Full Text] [Related]
4. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
[TBL] [Abstract][Full Text] [Related]
5. Diagnostics of ovarian cancer via metabolite analysis and machine learning.
Yao JZ; Tsigelny IF; Kesari S; Kouznetsova VL
Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37032481
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer detection by DNA methylation in cervical scrapings.
Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
[TBL] [Abstract][Full Text] [Related]
7. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
8. Using machine learning to predict ovarian cancer.
Lu M; Fan Z; Xu B; Chen L; Zheng X; Li J; Znati T; Mi Q; Jiang J
Int J Med Inform; 2020 Sep; 141():104195. PubMed ID: 32485554
[TBL] [Abstract][Full Text] [Related]
9. Proteomic pattern of cervico-vaginal fluid (CVF) in an ovarian cancer diagnosis - pilot study.
Gasiorowska E; Urbaniak B; Lorek J; Matysiak J; Nowak-Markwitz E
Ginekol Pol; 2018; 89(12):688-694. PubMed ID: 30618037
[TBL] [Abstract][Full Text] [Related]
10. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
Xiao Y; Bi M; Guo H; Li M
EBioMedicine; 2022 May; 79():104001. PubMed ID: 35439677
[TBL] [Abstract][Full Text] [Related]
12. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers.
Farinella F; Merone M; Bacco L; Capirchio A; Ciccozzi M; Caligiore D
Sci Rep; 2022 Feb; 12(1):3041. PubMed ID: 35197484
[TBL] [Abstract][Full Text] [Related]
14. Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
Robotti M; Scebba F; Angeloni D
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979630
[TBL] [Abstract][Full Text] [Related]
15. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma.
Lee YH; Kim JH; Zhou H; Kim BW; Wong DT
J Mol Med (Berl); 2012 Apr; 90(4):427-34. PubMed ID: 22095100
[TBL] [Abstract][Full Text] [Related]
16. Urinary interleukin-1β levels among gynecological patients.
Woolery KT; Hoffman MS; Kraft J; Nicosia SV; Kumar A; Kruk PA
J Ovarian Res; 2014 Nov; 7():104. PubMed ID: 25403235
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
18. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.
Davenport C; Rai N; Sharma P; Deeks JJ; Berhane S; Mallett S; Saha P; Champaneria R; Bayliss SE; Snell KI; Sundar S
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011964. PubMed ID: 35879201
[TBL] [Abstract][Full Text] [Related]
19. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
[TBL] [Abstract][Full Text] [Related]
20. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
